The clinical and diagnostic implications of mosaicism in the neurofibromatoses

Neurology

Volumn 56, Issue 11, 2001, Pages 1433-1443

  Ruggieri, Martino ^a   Huson, Susan M ^b  

^a CNR   (Italy)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MOSAICISM; NERVOUS SYSTEM TUMOR; NEURILEMOMA; NEUROFIBROMATOSIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SCHOOL CHILD; SOMATIC MUTATION;

EID: 0035849530     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.11.1433     Document Type: Review

References (61)

1. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
2. Gene structure and expression
3. Neurofibromatosis 2. Molecular biology
4. Neurofibromatosis 1: A clinical and genetic overview
5. Von Recklinghausen neurofibromatosis
6. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 children < 6 years and clinically suspected of having NF1
7. A clinical study of type 2 neurofibromatosis
8. The various presentations of neurofibromatosis type 2 (NF2) in childhood
9. The diagnosis and management of neurofibromatosis type 2 in childhood
10. Familial meningioma is not allelic to neurofibromatosis type 2
11. Schwannomatosis: A clinical and pathologic study
12. Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: A clinical and molecular study
13. Molecular analysis of the Nf2 tumor-suppressor gene in schwannomatosis
14. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and Schwannomas
15. Review and hypotheses: Somatic mosaicism: Observations related to clinical genetics
16. Principles of genetics, mosaicism and molecular biology
17. Germ line mosaicism
18. Revertant mosaicism in human genetic disorders
19. Mosaicism in human skin. Understanding the patterns and mechanisms
20. Segmental forms of autosomal dominant skin disorders: The puzzle of mosaicism
21. International Symposium on Mosaicism in Human Skin in honour of Rudolf Happle
22. Pigmentary patterns associated with human mosaicism: A proposed classification
23. Extracutaneous anomalies of Blaschko lines
24. High rate of mosaicism in tuberous sclerosis complex
25. Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father
26. Paternal origin of new mutations in von Recklinghausen neurofibromatosis
27. Mutations in von Recklinghausen neurofibromatosis: An hypothesis
28. Do NF1 gene deletions result in a characteristic phenotype?
29. Somatic mosaicism for deletion of the entire NF1 gene identified by FISH
30. NF1 microdeletion syndrome: Refined FISH characterization of sporadic and familial deletions with locus-specific probes
31. Somatic mosaicism in a patient with neurofibromatosis type 1
32. Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to maternally derived deletion
33. Exhaustive mutation analysis for the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects
34. Segregation analysis of peripheral neurofibromatosis
35. Somatic mosaicism: A common cause of classic disease in tumour-prone syndromes? Lessons from type 2 neurofibromatosis
36. Localized neurofibromatosis
37. Segmental neurofibromatosis
38. Neurofibromatosis: Clinical heterogeneity
39. Segmental neurofibromatosis
40. Alternate and related forms of the neurofibromatoses
41. Neurofibromatosis 2. Clinical aspects
42. The neurofibromatoses
43. More on the frequency of segmental neurofibromatosis
44. Segmental neurofibromatosis: Is it uncommon or underdiagnosed?
45. A rule concerning the segmental manifestations of autosomal dominant skin disorders: Review of clinical examples providing evidence for dichotomous types of severity
46. Malignant peripheral nerve sheath tumours in the setting of segmental neurofibromatosis
47. Segmental neurofibromatosis: Analysis of 14 cases
48. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene
49. What is segmental neurofibromatosis?
50. Familial transmission of segmental neurofibromatosis
51. Segmental neurofibromatosis of the sciatic nerve: Case report
52. A pairing-sensitive element that mediates trans-inactivation is associated with the Drosophila brown gene
53. Cell lineage and cell commitment in the early mammalian embryo
54. A mutation in the neurofibromatosis type 2 tumour-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals
55. Misleading linkage results in an Nf2 presymptomatic test owing to mosaicism
56. Mosaicism in sporadic neurofibromatosis 2 patients
57. Somatic mosaicism of the neurofibromatosis type 2 suppressor-gene
58. Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity